ATAI icon

ATAI Life Sciences
ATAI

Overview Fund Activity

97 hedge funds and large institutions have $74.2M invested in ATAI Life Sciences in 2022 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 36 increasing their positions, 11 reducing their positions, and 17 closing their positions.

Holders
97
Holders Change
+10
Holders Change %
+11.49%
% of All Funds
1.64%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
27
Increased
36
Reduced
11
Closed
17
Calls
$1.72M
Puts
$460K
Net Calls
+$1.26M
Net Calls Change
+$8.41M

Top Buyers

1
RCMNY
1
Rubric Capital Management (New York)
New York
$4.8M
2
SCM
2
Suvretta Capital Management
New York
$4.42M
3
RTS
3
Round Table Services
New Jersey
$2.56M
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$1.75M
5
Morgan Stanley
5
Morgan Stanley
New York
$7.84M

Top Sellers

1
PVI
1
Pura Vida Investments
New York
$2.63M
2
Group One Trading
2
Group One Trading
Illinois
$17K
3
GAMA
3
Graticule Asia Macro Advisors
New York
$0
4
AC
4
Antara Capital
New York
$0
5
GGHC
5
Gilder Gagnon Howe & Co
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
LC
101
Lindbrook Capital
California
– -$171K -33,674 Closed
Voloridge Investment Management
102
Voloridge Investment Management
Florida
– -$154K -30,225 Closed
GCP
103
GSA Capital Partners
United Kingdom
– -$122K -23,935 Closed
GG
104
Gofen & Glossberg
Illinois
– -$116K -22,800 Closed
CCP
105
Clarkston Capital Partners
Michigan
– -$75K -14,817 Closed
Walleye Capital
106
Walleye Capital
New York
– -$62K -12,249 Closed
MA
107
MYDA Advisors
New York
– -$61K -12,000 Closed
FIA
108
FNY Investment Advisers
New York
– -$9K -1,800 Closed
CG
109
Cutler Group
California
– -$3K -700 Closed
1 2 3 4
5